Regulus Book Value Per Share vs Pe Ratio Analysis

RGLS Stock  USD 1.64  0.07  4.46%   
Regulus Therapeutics financial indicator trend analysis is much more than just breaking down Regulus Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Regulus Therapeutics is a good investment. Please check the relationship between Regulus Therapeutics Book Value Per Share and its Pe Ratio accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regulus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Regulus Stock please use our How to Invest in Regulus Therapeutics guide.

Book Value Per Share vs Pe Ratio

Book Value Per Share vs Pe Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Regulus Therapeutics Book Value Per Share account and Pe Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Regulus Therapeutics' Book Value Per Share and Pe Ratio is -0.28. Overlapping area represents the amount of variation of Book Value Per Share that can explain the historical movement of Pe Ratio in the same time period over historical financial statements of Regulus Therapeutics, assuming nothing else is changed. The correlation between historical values of Regulus Therapeutics' Book Value Per Share and Pe Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value Per Share of Regulus Therapeutics are associated (or correlated) with its Pe Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pe Ratio has no effect on the direction of Book Value Per Share i.e., Regulus Therapeutics' Book Value Per Share and Pe Ratio go up and down completely randomly.

Correlation Coefficient

-0.28
Relationship DirectionNegative 
Relationship StrengthInsignificant

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Pe Ratio

Most indicators from Regulus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Regulus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regulus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Regulus Stock please use our How to Invest in Regulus Therapeutics guide.At this time, Regulus Therapeutics' Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 18 M in 2024, whereas Selling General Administrative is likely to drop slightly above 9.4 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense855K688K604K1.1M
Depreciation And Amortization459K122K227K215.7K

Regulus Therapeutics fundamental ratios Correlations

-0.55-0.320.90.070.360.640.78-0.02-0.40.950.590.1-0.230.710.230.660.230.07-0.550.550.4-0.120.970.13-0.29
-0.550.23-0.440.150.050.07-0.780.240.15-0.50.04-0.170.15-0.290.14-0.360.13-0.07-0.13-0.24-0.03-0.15-0.61-0.10.1
-0.320.23-0.40.130.5-0.48-0.15-0.21-0.23-0.25-0.180.21-0.02-0.020.490.30.48-0.120.53-0.180.43-0.2-0.38-0.130.08
0.9-0.44-0.4-0.270.230.720.66-0.2-0.150.780.62-0.33-0.530.40.090.480.09-0.24-0.680.210.220.070.88-0.250.08
0.070.150.13-0.270.15-0.16-0.020.56-0.550.24-0.130.810.750.670.230.20.220.860.240.790.26-0.510.070.88-0.88
0.360.050.50.230.150.190.320.06-0.460.410.480.28-0.160.450.870.740.87-0.25-0.070.120.89-0.320.280.040.0
0.640.07-0.480.72-0.160.190.280.16-0.210.580.73-0.25-0.340.370.150.340.15-0.16-0.980.250.22-0.160.61-0.15-0.03
0.78-0.78-0.150.66-0.020.320.28-0.23-0.390.780.20.19-0.180.550.20.690.210.01-0.170.40.39-0.040.80.14-0.18
-0.020.24-0.21-0.20.560.060.16-0.23-0.210.04-0.050.410.270.340.24-0.070.230.46-0.10.410.22-0.27-0.020.49-0.48
-0.40.15-0.23-0.15-0.55-0.46-0.21-0.39-0.21-0.53-0.24-0.63-0.26-0.78-0.32-0.75-0.3-0.520.11-0.72-0.410.88-0.45-0.50.58
0.95-0.5-0.250.780.240.410.580.780.04-0.530.570.29-0.060.840.280.740.280.22-0.490.690.46-0.180.940.29-0.44
0.590.04-0.180.62-0.130.480.730.2-0.05-0.240.57-0.12-0.240.390.40.510.41-0.26-0.720.160.44-0.160.51-0.130.05
0.1-0.170.21-0.330.810.28-0.250.190.41-0.630.29-0.120.730.680.30.410.30.720.340.740.36-0.510.130.87-0.81
-0.230.15-0.02-0.530.75-0.16-0.34-0.180.27-0.26-0.06-0.240.730.29-0.14-0.09-0.150.730.360.56-0.14-0.3-0.220.88-0.75
0.71-0.29-0.020.40.670.450.370.550.34-0.780.840.390.680.290.40.740.390.59-0.260.920.54-0.520.710.63-0.77
0.230.140.490.090.230.870.150.20.24-0.320.280.40.3-0.140.40.61.0-0.19-0.050.080.98-0.230.130.06-0.03
0.66-0.360.30.480.20.740.340.69-0.07-0.750.740.510.41-0.090.740.60.60.02-0.210.480.72-0.470.650.18-0.26
0.230.130.480.090.220.870.150.210.23-0.30.280.410.3-0.150.391.00.6-0.21-0.050.070.98-0.220.140.04-0.01
0.07-0.07-0.12-0.240.86-0.25-0.160.010.46-0.520.22-0.260.720.730.59-0.190.02-0.210.190.83-0.13-0.480.130.83-0.91
-0.55-0.130.53-0.680.24-0.07-0.98-0.17-0.10.11-0.49-0.720.340.36-0.26-0.05-0.21-0.050.19-0.16-0.10.11-0.530.23-0.04
0.55-0.24-0.180.210.790.120.250.40.41-0.720.690.160.740.560.920.080.480.070.83-0.160.22-0.520.580.81-0.93
0.4-0.030.430.220.260.890.220.390.22-0.410.460.440.36-0.140.540.980.720.98-0.13-0.10.22-0.250.310.12-0.13
-0.12-0.15-0.20.07-0.51-0.32-0.16-0.04-0.270.88-0.18-0.16-0.51-0.3-0.52-0.23-0.47-0.22-0.480.11-0.52-0.25-0.17-0.420.44
0.97-0.61-0.380.880.070.280.610.8-0.02-0.450.940.510.13-0.220.710.130.650.140.13-0.530.580.31-0.170.15-0.29
0.13-0.1-0.13-0.250.880.04-0.150.140.49-0.50.29-0.130.870.880.630.060.180.040.830.230.810.12-0.420.15-0.9
-0.290.10.080.08-0.880.0-0.03-0.18-0.480.58-0.440.05-0.81-0.75-0.77-0.03-0.26-0.01-0.91-0.04-0.93-0.130.44-0.29-0.9
Click cells to compare fundamentals

Regulus Therapeutics Account Relationship Matchups

Regulus Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets42.1M37.6M68.5M46.7M30.8M61.4M
Other Current Liab5.6M6.4M4.9M7.0M7.0M4.8M
Total Current Liabilities21.6M11.6M5.2M11.7M8.5M15.5M
Total Stockholder Equity20.0M26.0M55.0M33.3M21.2M35.4M
Other Liab10.0M7.1M468K1.2M1.1M1.0M
Accounts Payable1.3M535K285K175K204K193.8K
Cash34.1M31.1M60.4M24.2M23.8M35.1M
Other Assets0.024K291K1.00.90.86
Common Stock Shares Outstanding1.7M3.5M8.6M15.3M19.0M19.9M
Other Current Assets1.2M1.8M1.8M1.9M1.4M1.3M
Total Liab22.1M11.6M13.5M13.4M9.6M9.1M
Intangible Assets266K125K83K62K33K31.4K
Property Plant Equipment921K725K2.8M2.6M2.3M3.6M
Short Long Term Debt Total14.7M4.7M7.1M6.3M2.4M2.3M
Property Plant And Equipment Net921K472K2.8M2.6M2.5M3.6M
Current Deferred Revenue2.6M6K3.4M(589K)(530.1K)(503.6K)
Net Debt(19.5M)(26.4M)(53.3M)(17.9M)(21.4M)(22.4M)
Retained Earnings(411.3M)(427.0M)(454.9M)(483.2M)(513.2M)(487.6M)
Non Current Assets Total1.7M874K3.2M2.6M2.6M4.4M
Non Currrent Assets Other487K277K291K3.0M3.5M3.6M
Cash And Short Term Investments34.1M31.1M60.4M39.2M23.8M22.6M
Liabilities And Stockholders Equity42.1M37.6M68.5M46.7M30.8M29.2M
Non Current Liabilities Total468K5.2M8.3M1.8M1.1M1.0M
Other Stockholder Equity431.3M453.0M509.7M516.5M534.4M377.9M
Property Plant And Equipment Gross921K472K7.2M7.0M6.8M6.0M
Total Current Assets40.4M36.7M65.2M44.1M28.2M26.8M
Accumulated Other Comprehensive Income(134K)(9.9M)(4.4M)(12K)(1K)(1.1K)
Short Term Debt14.6M4.7M589K4.5M1.3M1.3M
Net Tangible Assets19.7M25.9M28.9M33.2M29.9M43.5M
Common Stock Total Equity104K9K21K67K77.1K53.0K
Retained Earnings Total Equity(345.9M)(392.7M)(411.3M)(427.0M)(384.3M)(403.6M)
Capital Surpluse381.1M386.9M431.3M453.0M521.0M356.5M
Inventory4.2M3.9M3.3M3.0K3.0M3.2M
Non Current Liabilities Other0.07.1M468K1.2M1.4M1.9M
Common Stock21K67K146K17K20K19K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Regulus Stock Analysis

When running Regulus Therapeutics' price analysis, check to measure Regulus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regulus Therapeutics is operating at the current time. Most of Regulus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Regulus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regulus Therapeutics' price. Additionally, you may evaluate how the addition of Regulus Therapeutics to your portfolios can decrease your overall portfolio volatility.